RE:RE:RE:RE:New Data Format
enriquesuave wrote: Th KM curve includes the 12 undertreated patients as it's the same data as Nvember.and shows 28% CR at 450 days. If we removed it we would get 67% CR
At this point in time, there are 19 active trial patients, 12 of whom are CR. There are currently 8 CRs at 450 days. Discounting the first 12 undertreated, if the current 12 remain CR until the 450 day endpoint, that would generously put us at 20 of 44 patients (or a 45% 12 month durable response rate).
Based on current trends & my brief analysis for the "actively participating" patients (which excludes the first 12), the overall durable response % is likely going to be in the 30%+ range. The reported 450 day 67% CR fails to account for those who fell out of the trial prior to the 450 day assessment (i.e. due to being a non-responder or for other individual reasons). All imo.